News

November 20, 2018 12:00 pm
MMRF Tribute Page - Creating one is a wonderful way to honor your, or a loved one’s, journey while supporting the MMRF’s mission towards a cure. Share your story and give others a chance to show their support of critical research.
November 11, 2018 10:45 am
November 8, 2018 12:00 pm
(New England Journal of Medicine) Abstract Background The immunostimulatory monoclonal antibody elotuzumab plus lenalidomide and dexamethasone has been shown to be effective in patients with relapsed or refractory multiple myeloma. The...

Pages